Central Nervous System Agents in Medicinal Chemistry
Title:Meet Our Editorial Board Members:
Volume: 16 Issue: 1
Author(s): Shaun Stauffer and Syed Masarrat Ali
Affiliation:
Export Options
About this article
Cite this article as:
Stauffer Shaun and Masarrat Ali Syed, Meet Our Editorial Board Members:, Central Nervous System Agents in Medicinal Chemistry 2016; 16 (1) . https://dx.doi.org/10.2174/187152491601151104094721
DOI https://dx.doi.org/10.2174/187152491601151104094721 |
Print ISSN 1871-5249 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6166 |
22
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Parkinsons Disease: Genetics and Beyond
Current Neuropharmacology Medicinal Chemistry of Antimigraine Drugs
Current Medicinal Chemistry Therapeutic Options in Prevention and Treatment of Aspartoacylase Gene Mutation Resulting Abnormalities in Canavan Disease
Current Pharmacogenomics Molecular Modeling: From Chemical-biological Structure to Pharmaco- medical Activity and Function
Current Medicinal Chemistry Revisiting Antipsychotic-induced Akathisia: Current Issues and Prospective Challenges
Current Neuropharmacology NF-κB Signaling and Carcinogenesis
Current Pharmaceutical Design Ethical Implications for Clinical Practice and Future Research in “At Risk” Individuals
Current Pharmaceutical Design Functional Connectivity in Elderly Controls and AD Patients Using Resting State fMRI: A Pilot Study
Current Alzheimer Research Vitamin-D Receptor (VDR) Gene Polymorphisms (TaqI, FokI) in Turkish Patients with Hashimoto’s Thyroiditis: Relationship to the Levels of Vit-D and Cytokines
Endocrine, Metabolic & Immune Disorders - Drug Targets Chemokine Receptors as Anti-Retroviral Targets
Current Drug Targets A Pharmacological Appraisal of Neuroprotective and Neurorestorative Flavonoids Against Neurodegenerative Diseases
CNS & Neurological Disorders - Drug Targets Targeting the Progression of Parkinsons Disease
Current Neuropharmacology Blockade of Ser16-Hsp20 Phosphorylation Attenuates Neuroprotection Dependent Upon Bcl-2 and Bax
Current Neurovascular Research Autoimmune Diseases and Infections: A Controversial Relationship
Current Immunology Reviews (Discontinued) Phosphodiesterase 10 Inhibitors: New Disease Modifying Drugs for Parkinson’s Disease?
Current Medicinal Chemistry Glucose Addiction in Cancer Therapy: Advances and Drawbacks
Current Drug Metabolism The Other Side of Opioid Receptor Signalling: Regulation by Protein-Protein Interaction
Current Drug Targets Patent Review
Combinatorial Chemistry & High Throughput Screening Cell-based Assays for Assessing Toxicity: A Basic Guide
Medicinal Chemistry Synthesis, in vitro Antiproliferative and Antiinflammatory Activities, and Kinase Inhibitory effects of New 1,3,4-triarylpyrazole Derivatives
Anti-Cancer Agents in Medicinal Chemistry